GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 826 - 850 of 4050 in total
Antibody Patient Onset (days) ▼ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G09482NW
455
IgA Patient 2 3 mild
G09609EN
986
IgA Patient 2 3 mild
G10133VD
867
IgA Patient 2 3 mild
G10789DJ
557
IgA Patient 2 3 mild
G11460AB
295
IgA Patient 2 3 mild
G12200GB
277
IgA Patient 2 3 mild
G14569AR
491
IgA Patient 2 3 mild
G14844CX
354
IgA Patient 2 3 mild
G14988WV
371
IgA Patient 2 3 mild
G15209MJ
462
IgA Patient 2 3 mild
G15407YE
4029
IgA Patient 2 3 mild
G16579HJ
472
IgA Patient 2 3 mild
G17140UR
576
IgA Patient 2 3 mild
G17266GE
336
IgA Patient 2 3 mild
G17390SF
516
IgA Patient 2 3 mild
G17689EW
366
IgA Patient 2 3 mild
G18057VI
356
IgA Patient 2 3 mild
G19118WX
569
IgA Patient 2 3 mild
G19868AX
401
IgA Patient 2 3 mild
G21290RB
535
IgA Patient 2 3 mild
G21320TF
313
IgA Patient 2 3 mild
G21460SG
405
IgA Patient 2 3 mild
G21675ZL
1838
IgA Patient 2 3 mild
G22768VO
1272
IgA Patient 2 3 mild
G24432YB
247

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024